Deutsche Bank’s Ernexa Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
Other funds holding ERNA
Deutsche Bank's ERNA Position: Q2 2022 in Review
Deutsche Bank sold out of Ernexa Therapeutics (ERNA) in Q2 2022, closing a stake of 2 shares — an estimated $35K sold.
Deutsche Bank first reported a position in ERNA in Q2 2021 and held it in 4 quarters. The position peaked at $273K in Q2 2021. 34 funds tracked by Wall St. Rank hold ERNA as of Q2 2022.
- Deutsche Bank reported no remaining Ernexa Therapeutics position as of Q2 2022 after selling out during the quarter.
- Deutsche Bank sold 2 Ernexa Therapeutics shares in Q2 2022, an estimated $35K.
- Deutsche Bank first reported a position in Ernexa Therapeutics in Q2 2021 and held it in 4 quarters.
- Deutsche Bank's Ernexa Therapeutics position peaked at $273K in Q2 2021.
- 34 funds tracked by Wall St. Rank held Ernexa Therapeutics as of Q2 2022.
Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.